EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Molecular targets of dietary agents for prevention and therapy of cancer


Biochemical Pharmacology 71(10): 1397-1421
Molecular targets of dietary agents for prevention and therapy of cancer
While fruits and vegetables are recommended for prevention of cancer and other diseases, their active ingredients (at the molecular level) and their mechanisms of action less well understood. Extensive research during the last half century has identified various molecular targets that can potentially be used not only for the prevention of cancer but also for treatment. However, lack of success with targeted monotherapy resulting from bypass mechanisms has forced researchers to employ either combination therapy or agents that interfere with multiple cell-signaling pathways. In this review, we present evidence that numerous agents identified from fruits and vegetables can interfere with several cell-signaling pathways. The agents include curcumin (turmeric), resveratrol (red grapes, groundnuts and berries), genistein soyabean, diallyl sulfide (allium), S-allyl cysteine (allium), allicin (garlic), lycopene (tomato), capsaicin (red chilli), diosgenin (fenugreek), 6-gingerol (ginger), ellagic acid (pomegranate), ursolic acid (apple, pears, prunes), silymarin (milk thistle), anethol (anise, camphor, and fennel), catechins (green tea), eugenol (cloves), indole-3-carbinol (cruciferous vegetables), limonene (citrus fruits), beta carotene (carrots), and dietary fibre. For instance, the cell-signaling pathways inhibited by curcumin alone include NF- kappa B, AP-1, STAT3, Akt, Bcl-2, Bcl-XL, caspases, PARP, IKK, EGFR, HER2, JNK, MAPK, COX2, and 5-LOX. The active principle identified in fruit and vegetables and the molecular targets modulated may be the basis for how these dietary agents not only prevent but also treat cancer and other diseases. This work reaffirms what Hippocrates said 25 centuries ago, let food be thy medicine and medicine be thy food.

Accession: 004452474

PMID: 16563357

DOI: 10.1016/j.bcp.2006.02.009

Download PDF Full Text: Molecular targets of dietary agents for prevention and therapy of cancer



Related references

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochemical Pharmacology 60(8): 1051-1059, 2000

Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clinical Epigenetics 1(3-4): 101-116, 2011

MiRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents. 2013

miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents. Current Cancer Drug Targets 13(5): 519-541, 2014

Molecular targets for cancer therapy and prevention. Chest 125(5 Suppl): 97s-101s, 2004

Molecular targets for breast cancer therapy and prevention. Nature Medicine 7(5): 548-552, 2001

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opinion on Therapeutic Targets 14(1): 45-55, 2010

AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. Emerging targets and new agents from academia. 14-18th November 2005, Philadelphia, PA, USA. Idrugs 9(1): 6-8, 2005

Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer. Anticancer Research 21(2a): 931-957, 2001

Identification of molecular targets for dietary energy restriction prevention of skin carcinogenesis: an idea cultivated by Edward Bresnick. Journal of Cellular Biochemistry 91(2): 258-264, 2004